FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiology, and deals with complex immunomodulating treatment of patients with chronic heart failure with reduced left ventricular heart ejection fraction. For this purpose in commonly accepted complex of drug therapy, which includes β-adrenoblockers, ACE inhibitors, diuretics, cardiomagnyl, additionally introduced is recombinant human interleukin 2 (IL-2). IL-2 is introduced in dose 500 IU/ml, in 200 ml of physiological solution, which containf for stabilisation 10 ml of 5% albumin solution, intravenously drop-by-drop daily 1 time for 10 days; treatment course is repeated 1 time per 3 months during 12 months.
EFFECT: complex treatment ensures suppression of chronic immune inflammation due to ability of IL-2 in elaborated mode of introduction to reduce level of endogenic cytokins and activate T- and B- lymphocytes efficiently in said group of patients.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2428980C1 |
| METHOD OF TREATING PATIENTS SUFFERING CHRONIC CARDIAC FAILURE COMPROMISED TYPE 2 DIABETES | 2010 |
|
RU2421218C1 |
| METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC CARDIAC INSUFFICIENCY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2599501C1 |
| METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
| METHOD FOR PERSONALIZED SELECTION OF PATIENTS WITH ANTHRACYCLINE-INDUCED CARDIOMYOPATHY AFTER POLYCHEMOTHERAPY OF BREAST CANCER FOR EFFECTIVE TREATMENT WITH CARVEDILOL | 2021 |
|
RU2778612C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF CHRONIC CARDIAC FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2545899C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WITHIN 12 MONTHS AFTER DECOMPENSATION OF CHRONIC HEART INSUFFICIENCY | 2020 |
|
RU2756391C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
